FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

32438611000001108: Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1871381000001112 Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1871391000001114 Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
98666001000001110 Olanzapine 7.5mg tablets (Kent Pharmaceuticals Ltd) 56 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
98666101000001111 Olanzapine 7.5mg tablets (Kent Pharmaceuticals Ltd) 56 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Is a Olanzapine 7.5mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has AMP Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has specific active ingredient Olanzapine true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Olanzapine 7.5mg tablets (Kent Pharma (UK) Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start